MNDL Bio
Tel Aviv, Israel· Est.
AI‑powered DNA engineering platform that accelerates and scales recombinant protein production for biotech and industrial customers.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
AI‑powered DNA engineering platform that accelerates and scales recombinant protein production for biotech and industrial customers.
BiologicsIndustrial enzymes
Technology Platform
AI‑driven, physics‑guided DNA design that optimizes whole‑construct sequences for host‑specific recombinant protein expression, delivering synthesis‑ready DNA.
Opportunities
Expansion into new host systems and high‑throughput automation can broaden market reach across biologics, industrial enzymes and synthetic‑biology applications.
Risk Factors
Model validation across diverse proteins and hosts, competition from larger synthetic‑biology platforms, and converting early collaborations into recurring revenue pose significant challenges.
Competitive Landscape
Competes with Ginkgo Bioworks, Twist Bioscience and other DNA‑design services; differentiates through physics‑guided AI that offers more predictive whole‑construct optimization.